Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alzheimer's Disease

Free Subscription Articles published in Acta Neuropathol Retrieve available abstracts of 104 articles: HTML format

Single Articles

April 2024
1. BHATTARAI P, Gunasekaran TI, Belloy ME, Reyes-Dumeyer D, et al
   Rare genetic variation in fibronectin 1 (FN1) protects against APOEepsilon4 in Alzheimer's disease.
   Acta Neuropathol. 2024;147:70.
   PubMed     Abstract available
   
   
   
2. THAL DR, Gawor K, Moonen S
   Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis.
   Acta Neuropathol. 2024;147:69.
   PubMed     Abstract available
   
   
   
3. JAISA-AAD M, Munoz-Castro C, Healey MA, Hyman BT, et al
   Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias.
   Acta Neuropathol. 2024;147:66.
   PubMed     Abstract available
   
   
   
4. WACHTER A, Woodbury ME, Lombardo S, Abdourahman A, et al
   Landscape of brain myeloid cell transcriptome along the spatiotemporal progression of Alzheimer's disease reveals distinct sequential responses to Abeta and tau.
   Acta Neuropathol. 2024;147:65.
   PubMed     Abstract available
   
   
   March 2024
5. BOUTER Y, Noguerola JSL, Tucholla P, Crespi GAN, et al
   Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models.
   Acta Neuropathol. 2024;147:59.
   PubMed    
   
   
   
6. MALDONADO-DIAZ C, Hiya S, Yokoda RT, Farrell K, et al
   Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies.
   Acta Neuropathol. 2024;147:58.
   PubMed     Abstract available
   
   
   
7. XU H, Qiu Q, Hu P, Hoxha K, et al
   MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons.
   Acta Neuropathol. 2024;147:55.
   PubMed     Abstract available
   
   
   
8. WALTON RL, Koga S, Beasley AI, White LJ, et al
   Role of GBA variants in Lewy body disease neuropathology.
   Acta Neuropathol. 2024;147:54.
   PubMed     Abstract available
   
   
   February 2024
9. ALEXANDER A, Alvarez VE, Huber BR, Alosco ML, et al
   Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE.
   Acta Neuropathol. 2024;147:45.
   PubMed     Abstract available
   
   
   
10. MALIK N, Miah MU, Galgani A, McAleese K, et al
    Regional AT-8 reactive tau species correlate with intracellular Abeta levels in cases of low AD neuropathologic change.
    Acta Neuropathol. 2024;147:40.
    PubMed     Abstract available
    
    
    
11. WU YC, Bogale TA, Koistinaho J, Pizzi M, et al
    The contribution of beta-amyloid, Tau and alpha-synuclein to blood-brain barrier damage in neurodegenerative disorders.
    Acta Neuropathol. 2024;147:39.
    PubMed     Abstract available
    
    
    
12. COLOM-CADENA M, Toombs J, Simzer E, Holt K, et al
    Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease.
    Acta Neuropathol. 2024;147:32.
    PubMed     Abstract available
    
    
    
13. OERTEL FC, Casillas D, Cobigo Y, Condor Montes S, et al
    Scientific commentary on: "Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies".
    Acta Neuropathol. 2024;147:30.
    PubMed    
    
    
    
14. CHUNG M, Carter EK, Veire AM, Dammer EB, et al
    Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains.
    Acta Neuropathol. 2024;147:29.
    PubMed     Abstract available
    
    
    January 2024
15. LEITNER D, Pires G, Kavanagh T, Kanshin E, et al
    Similar brain proteomic signatures in Alzheimer's disease and epilepsy.
    Acta Neuropathol. 2024;147:27.
    PubMed     Abstract available
    
    
    
16. AGUERO C, Dhaynaut M, Amaral AC, Moon SH, et al
    Head-to-head comparison of [(18)F]-Flortaucipir, [(18)F]-MK-6240 and [(18)F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases.
    Acta Neuropathol. 2024;147:25.
    PubMed     Abstract available
    
    
    
17. FAZELI E, Child DD, Bucks SA, Stovarsky M, et al
    A familial missense variant in the Alzheimer's disease gene SORL1 impairs its maturation and endosomal sorting.
    Acta Neuropathol. 2024;147:20.
    PubMed     Abstract available
    
    
    
18. VAN DER GAAG BL, Deshayes NAC, Breve JJP, Bol JGJM, et al
    Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.
    Acta Neuropathol. 2024;147:14.
    PubMed     Abstract available
    
    
    
19. LANTERO-RODRIGUEZ J, Montoliu-Gaya L, Benedet AL, Vrillon A, et al
    CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.
    Acta Neuropathol. 2024;147:12.
    PubMed     Abstract available
    
    
    
20. AGRA ALMEIDA QUADROS AR, Li Z, Wang X, Ndayambaje IS, et al
    Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease.
    Acta Neuropathol. 2024;147:9.
    PubMed     Abstract available
    
    
    
21. TAYLOR LW, Simzer EM, Pimblett C, Lacey-Solymar OTT, et al
    p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003.
    Acta Neuropathol. 2024;147:7.
    PubMed     Abstract available
    
    
    December 2023
22. MONTOLIU-GAYA L, Alosco ML, Yhang E, Tripodis Y, et al
    Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study.
    Acta Neuropathol. 2023;147:5.
    PubMed     Abstract available
    
    
    
23. CHANG K, Ling JP, Redding-Ochoa J, An Y, et al
    Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer's disease neuropathologic changes and cognitive decline.
    Acta Neuropathol. 2023;147:4.
    PubMed     Abstract available
    
    
    November 2023
24. VANDEVREDE L, La Joie R, Horiki S, Mundada NS, et al
    Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.
    Acta Neuropathol. 2023;146:777-781.
    PubMed    
    
    
    September 2023
25. SORDO L, Qian T, Bukhari SA, Nguyen KM, et al
    Characterization of hippocampal sclerosis of aging and its association with other neuropathologic changes and cognitive deficits in the oldest-old.
    Acta Neuropathol. 2023;146:415-432.
    PubMed     Abstract available
    
    
    August 2023
26. NGUYEN AT, Wang K, Hu G, Wang X, et al
    Correction: APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer's disease.
    Acta Neuropathol. 2023 Aug 17. doi: 10.1007/s00401-023-02620.
    PubMed    
    
    
    
27. JUDD JM, Jasbi P, Winslow W, Serrano GE, et al
    Inflammation and the pathological progression of Alzheimer's disease are associated with low circulating choline levels.
    Acta Neuropathol. 2023 Aug 7. doi: 10.1007/s00401-023-02616.
    PubMed     Abstract available
    
    
    
28. MATE DE GERANDO A, Welikovitch LA, Khasnavis A, Commins C, et al
    Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau.
    Acta Neuropathol. 2023;146:191-210.
    PubMed     Abstract available
    
    
    July 2023
29. NEUMANN M, Perneel J, Cheung S, Van den Broeck M, et al
    Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology.
    Acta Neuropathol. 2023;146:163-166.
    PubMed    
    
    
    
30. YU L, Boyle PA, Janelidze S, Petyuk VA, et al
    Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults.
    Acta Neuropathol. 2023;146:1-11.
    PubMed     Abstract available
    
    
    June 2023
31. BERMUDEZ C, Graff-Radford J, Syrjanen JA, Stricker NH, et al
    Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change.
    Acta Neuropathol. 2023 Jun 3. doi: 10.1007/s00401-023-02594.
    PubMed     Abstract available
    
    
    
32. FILIPELLO F, You SF, Mirfakhar FS, Mahali S, et al
    Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.
    Acta Neuropathol. 2023;145:749-772.
    PubMed     Abstract available
    
    
    May 2023
33. MANCA M, Standke HG, Browne DF, Huntley ML, et al
    Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases.
    Acta Neuropathol. 2023 May 8. doi: 10.1007/s00401-023-02574.
    PubMed     Abstract available
    
    
    
34. HOQ MR, Bharath SR, Hallinan GI, Fernandez A, et al
    Cross-beta helical filaments of Tau and TMEM106B in gray and white matter of multiple system tauopathy with presenile dementia.
    Acta Neuropathol. 2023;145:707-710.
    PubMed    
    
    
    March 2023
35. CHENG Y, He CY, Tian DY, Chen SH, et al
    Physiological beta-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease.
    Acta Neuropathol. 2023 Mar 25. doi: 10.1007/s00401-023-02559.
    PubMed     Abstract available
    
    
    
36. WINFREE RL, Seto M, Dumitrescu L, Menon V, et al
    TREM2 gene expression associations with Alzheimer's disease neuropathology are region-specific: implications for cortical versus subcortical microglia.
    Acta Neuropathol. 2023 Mar 25. doi: 10.1007/s00401-023-02564.
    PubMed     Abstract available
    
    
    
37. YANG Y, Zhang W, Murzin AG, Schweighauser M, et al
    Cryo-EM structures of amyloid-beta filaments with the Arctic mutation (E22G) from human and mouse brains.
    Acta Neuropathol. 2023;145:325-333.
    PubMed     Abstract available
    
    
    February 2023
38. BOZA-SERRANO A, Ruiz R, Sanchez-Varo R, Garcia-Revilla J, et al
    Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
    Acta Neuropathol. 2023 Feb 15. doi: 10.1007/s00401-023-02549.
    PubMed    
    
    
    
39. KORONYO Y, Rentsendorj A, Mirzaei N, Regis GC, et al
    Retinal pathological features and proteome signatures of Alzheimer's disease.
    Acta Neuropathol. 2023 Feb 11. doi: 10.1007/s00401-023-02548.
    PubMed     Abstract available
    
    
    
40. NELSON PT, Lee EB, Cykowski MD, Alafuzoff I, et al
    LATE-NC staging in routine neuropathologic diagnosis: an update.
    Acta Neuropathol. 2023;145:159-173.
    PubMed     Abstract available
    
    
    January 2023
41. KIM YA, Siddiqui T, Blaze J, Cosacak MI, et al
    RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation.
    Acta Neuropathol. 2023;145:29-48.
    PubMed     Abstract available
    
    
    December 2022
42. HART DE RUYTER FJ, Morrema THJ, den Haan J, Twisk JWR, et al
    Correction to: Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.
    Acta Neuropathol. 2022 Dec 23. doi: 10.1007/s00401-022-02534.
    PubMed    
    
    
    
43. SCADUTO P, Lauterborn JC, Cox CD, Fracassi A, et al
    Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer's disease neuropathologic change.
    Acta Neuropathol. 2022 Dec 20. doi: 10.1007/s00401-022-02526.
    PubMed     Abstract available
    
    
    
44. MOONEN S, Koper MJ, Van Schoor E, Schaeverbeke JM, et al
    Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
    Acta Neuropathol. 2022 Dec 9. doi: 10.1007/s00401-022-02528.
    PubMed     Abstract available
    
    
    
45. HART DE RUYTER FJ, Morrema THJ, den Haan J, Twisk JWR, et al
    Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.
    Acta Neuropathol. 2022 Dec 8. doi: 10.1007/s00401-022-02525.
    PubMed     Abstract available
    
    
    
46. ICHIMATA S, Martinez-Valbuena I, Forrest SL, Kovacs GG, et al
    Expanding the spectrum of amyloid-beta plaque pathology: the Down syndrome associated 'bird-nest plaque'.
    Acta Neuropathol. 2022;144:1171-1174.
    PubMed    
    
    
    
47. NGUYEN AT, Kouri N, Labuzan SA, Przybelski SA, et al
    Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI.
    Acta Neuropathol. 2022;144:1117-1125.
    PubMed     Abstract available
    
    
    October 2022
48. GILVESY A, Husen E, Magloczky Z, Mihaly O, et al
    Spatiotemporal characterization of cellular tau pathology in the human locus coeruleus-pericoerulear complex by three-dimensional imaging.
    Acta Neuropathol. 2022;144:651-676.
    PubMed     Abstract available
    
    
    September 2022
49. KIM B, Suh E, Nguyen AT, Prokop S, et al
    TREM2 risk variants are associated with atypical Alzheimer's disease.
    Acta Neuropathol. 2022 Sep 16. pii: 10.1007/s00401-022-02495.
    PubMed     Abstract available
    
    
    
50. SHANG Y, Sun X, Chen X, Wang Q, et al
    A CHCHD6-APP axis connects amyloid and mitochondrial pathology in Alzheimer's disease.
    Acta Neuropathol. 2022 Sep 14. pii: 10.1007/s00401-022-02499.
    PubMed     Abstract available
    
    
    
51. JANSEN IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, et al
    Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
    Acta Neuropathol. 2022 Sep 6. pii: 10.1007/s00401-022-02454.
    PubMed     Abstract available
    
    
    
52. BOTELLA LUCENA P, Vanherle S, Lodder C, Gutierrez de Rave M, et al
    Blood-based Abeta42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention.
    Acta Neuropathol. 2022;144:489-508.
    PubMed     Abstract available
    
    
    August 2022
53. COUGHLIN DG, Goodwill VS, Standke HG, Kim Y, et al
    Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer's disease.
    Acta Neuropathol. 2022 Aug 18. pii: 10.1007/s00401-022-02480.
    PubMed    
    
    
    
54. GAO F, Hu M, Zhang J, Hashem J, et al
    TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury.
    Acta Neuropathol. 2022;144:187-210.
    PubMed     Abstract available
    
    
    July 2022
55. BOZA-SERRANO A, Vrillon A, Minta K, Paulus A, et al
    Galectin-3 is elevated in CSF and is associated with Abeta deposits and tau aggregates in brain tissue in Alzheimer's disease.
    Acta Neuropathol. 2022 Jul 27. pii: 10.1007/s00401-022-02469.
    PubMed     Abstract available
    
    
    
56. AREZOUMANDAN S, Xie SX, Cousins KAQ, Mechanic-Hamilton DJ, et al
    Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer's disease.
    Acta Neuropathol. 2022 Jul 23. pii: 10.1007/s00401-022-02472.
    PubMed     Abstract available
    
    
    
57. SEPULVEDA-FALLA D, Sanchez JS, Almeida MC, Boassa D, et al
    Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia.
    Acta Neuropathol. 2022 Jul 15. pii: 10.1007/s00401-022-02467.
    PubMed     Abstract available
    
    
    
58. DENG Y, Bi M, Delerue F, Forrest SL, et al
    Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer's disease.
    Acta Neuropathol. 2022 Jul 3. pii: 10.1007/s00401-022-02457.
    PubMed     Abstract available
    
    
    
59. WANG SJ, Guo Y, Ervin JF, Lusk JB, et al
    Neuropathological associations of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) differ between the oldest-old and younger-old.
    Acta Neuropathol. 2022;144:45-57.
    PubMed     Abstract available
    
    
    June 2022
60. LYSSENKO NN, Shi X, Pratico D
    The Alzheimer's disease GWAS risk alleles in the ABCA7 promoter and 5' region reduce ABCA7 expression.
    Acta Neuropathol. 2022 Jun 27. pii: 10.1007/s00401-022-02459.
    PubMed    
    
    
    
61. NELSON PT, Brayne C, Flanagan ME, Abner EL, et al
    Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts.
    Acta Neuropathol. 2022 Jun 13. pii: 10.1007/s00401-022-02444.
    PubMed     Abstract available
    
    
    
62. LLOYD GM, Sorrentino ZA, Quintin S, Gorion KM, et al
    Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human alpha-synuclein transgenic mice.
    Acta Neuropathol. 2022;143:663-685.
    PubMed     Abstract available
    
    
    May 2022
63. LEE AJ, Raghavan NS, Bhattarai P, Siddiqui T, et al
    FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease.
    Acta Neuropathol. 2022 May 24. pii: 10.1007/s00401-022-02431.
    PubMed     Abstract available
    
    
    
64. PLOWEY ED, Bussiere T, Rajagovindan R, Sebalusky J, et al
    Alzheimer disease neuropathology in a patient previously treated with aducanumab.
    Acta Neuropathol. 2022 May 17. pii: 10.1007/s00401-022-02433.
    PubMed     Abstract available
    
    
    
65. CHEN S, Acosta D, Li L, Liang J, et al
    Wolframin is a novel regulator of tau pathology and neurodegeneration.
    Acta Neuropathol. 2022;143:547-569.
    PubMed     Abstract available
    
    
    
66. CYKOWSKI MD, Arumanayagam AS, Powell SZ, Rivera AL, et al
    Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies.
    Acta Neuropathol. 2022;143:531-545.
    PubMed     Abstract available
    
    
    April 2022
67. JIN Y, Li F, Sonoustoun B, Kondru NC, et al
    APOE4 exacerbates alpha-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
    Acta Neuropathol. 2022 Apr 26. pii: 10.1007/s00401-022-02421.
    PubMed     Abstract available
    
    
    
68. BOUTER Y, Liekefeld H, Pichlo S, Westhoff AC, et al
    Donanemab detects a minor fraction of amyloid-beta plaques in post-mortem brain tissue of patients with Alzheimer's disease and Down syndrome.
    Acta Neuropathol. 2022 Apr 16. pii: 10.1007/s00401-022-02418.
    PubMed    
    
    
    
69. RAMANAN VK, Heckman MG, Lesnick TG, Przybelski SA, et al
    Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer's disease.
    Acta Neuropathol. 2022 Apr 12. pii: 10.1007/s00401-022-02419.
    PubMed     Abstract available
    
    
    
70. BARON T, Arsac JN, Verchere J, Tlili H, et al
    Co-expression of APP/PS1 disrupts the distribution of brain lesions in a synucleinopathy transgenic mouse model (M83).
    Acta Neuropathol. 2022;143:527-529.
    PubMed    
    
    
    March 2022
71. KAPASI A, Yu L, Petyuk V, Arfanakis K, et al
    Association of small vessel disease with tau pathology.
    Acta Neuropathol. 2022;143:349-362.
    PubMed     Abstract available
    
    
    
72. PEROSA V, Oltmer J, Munting LP, Freeze WM, et al
    Perivascular space dilation is associated with vascular amyloid-beta accumulation in the overlying cortex.
    Acta Neuropathol. 2022;143:331-348.
    PubMed     Abstract available
    
    
    February 2022
73. SMIRNOV DS, Ashton NJ, Blennow K, Zetterberg H, et al
    Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change.
    Acta Neuropathol. 2022 Feb 23. pii: 10.1007/s00401-022-02408.
    PubMed     Abstract available
    
    
    
74. KAESER SA, Hasler LM, Lambert M, Bergmann C, et al
    CSF p-tau increase in response to Abeta-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles.
    Acta Neuropathol. 2022;143:287-290.
    PubMed    
    
    
    
75. BOWLES KR, Pugh DA, Oja LM, Jadow BM, et al
    Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD.
    Acta Neuropathol. 2022;143:225-243.
    PubMed     Abstract available
    
    
    January 2022
76. UEMURA MT, Robinson JL, Cousins KAQ, Tropea TF, et al
    Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
    Acta Neuropathol. 2022;143:15-31.
    PubMed     Abstract available
    
    
    November 2021
77. SMITH AM, Davey K, Tsartsalis S, Khozoie C, et al
    Diverse human astrocyte and microglial transcriptional responses to Alzheimer's pathology.
    Acta Neuropathol. 2021 Nov 12. pii: 10.1007/s00401-021-02372.
    PubMed     Abstract available
    
    
    October 2021
78. MCALEESE KE, Miah M, Graham S, Hadfield GM, et al
    Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology.
    Acta Neuropathol. 2021 Oct 4. pii: 10.1007/s00401-021-02376.
    PubMed     Abstract available
    
    
    
79. ROOS TT, Garcia MG, Martinsson I, Mabrouk R, et al
    Neuronal spreading and plaque induction of intracellular Abeta and its disruption of Abeta homeostasis.
    Acta Neuropathol. 2021;142:669-687.
    PubMed     Abstract available
    
    
    
80. MAO F, Robinson JL, Unger T, Posavi M, et al
    TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy.
    Acta Neuropathol. 2021;142:629-642.
    PubMed     Abstract available
    
    
    September 2021
81. FELEKE R, Reynolds RH, Smith AM, Tilley B, et al
    Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases.
    Acta Neuropathol. 2021;142:449-474.
    PubMed     Abstract available
    
    
    August 2021
82. HALLINAN GI, Hoq MR, Ghosh M, Vago FS, et al
    Structure of Tau filaments in Prion protein amyloidoses.
    Acta Neuropathol. 2021;142:227-241.
    PubMed     Abstract available
    
    
    
83. WALLON D, Boluda S, Rovelet-Lecrux A, Thierry M, et al
    Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers.
    Acta Neuropathol. 2021;142:259-278.
    PubMed     Abstract available
    
    
    July 2021
84. CHEN CD, Joseph-Mathurin N, Sinha N, Zhou A, et al
    Comparing amyloid-beta plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease.
    Acta Neuropathol. 2021 Jul 28. pii: 10.1007/s00401-021-02342.
    PubMed     Abstract available
    
    
    June 2021
85. DIAZ-LUCENA D, Kruse N, Thune K, Schmitz M, et al
    TREM2 expression in the brain and biological fluids in prion diseases.
    Acta Neuropathol. 2021;141:841-859.
    PubMed     Abstract available
    
    
    May 2021
86. JAUNMUKTANE Z, Banerjee G, Paine S, Parry-Jones A, et al
    Alzheimer's disease neuropathological change three decades after iatrogenic amyloid-beta transmission.
    Acta Neuropathol. 2021 May 28. pii: 10.1007/s00401-021-02326.
    PubMed    
    
    
    
87. DAVE N, Vural AS, Piras IS, Winslow W, et al
    Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies.
    Acta Neuropathol. 2021 May 12. pii: 10.1007/s00401-021-02323.
    PubMed     Abstract available
    
    
    
88. GARCIA-ESCUDERO V, Ruiz-Gabarre D, Gargini R, Perez M, et al
    A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease.
    Acta Neuropathol. 2021 May 2. pii: 10.1007/s00401-021-02317.
    PubMed     Abstract available
    
    
    April 2021
89. KANG SS, Ahn EH, Liu X, Bryson M, et al
    ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease.
    Acta Neuropathol. 2021 Apr 25. pii: 10.1007/s00401-021-02315.
    PubMed     Abstract available
    
    
    
90. VALVERDE A, Dunys J, Lorivel T, Debayle D, et al
    Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer's disease (AD) mouse model and is increased at early stage in sporadic AD brain.
    Acta Neuropathol. 2021 Apr 21. pii: 10.1007/s00401-021-02308.
    PubMed     Abstract available
    
    
    
91. SHI Y, Murzin AG, Falcon B, Epstein A, et al
    Correction to: Cryo-EM structures of tau filaments from Alzheimer's disease with PET ligand APN-1607.
    Acta Neuropathol. 2021 Apr 8. pii: 10.1007/s00401-021-02303.
    PubMed    
    
    
    
92. TOME SO, Gomes LA, Li X, Vandenberghe R, et al
    TDP-43 interacts with pathological tau protein in Alzheimer's disease.
    Acta Neuropathol. 2021 Apr 2. pii: 10.1007/s00401-021-02295.
    PubMed    
    
    
    March 2021
93. SHI Y, Murzin AG, Falcon B, Epstein A, et al
    Cryo-EM structures of tau filaments from Alzheimer's disease with PET ligand APN-1607.
    Acta Neuropathol. 2021 Mar 16. pii: 10.1007/s00401-021-02294.
    PubMed     Abstract available
    
    
    February 2021
94. GERRITS E, Brouwer N, Kooistra SM, Woodbury ME, et al
    Distinct amyloid-beta and tau-associated microglia profiles in Alzheimer's disease.
    Acta Neuropathol. 2021 Feb 20. pii: 10.1007/s00401-021-02263.
    PubMed     Abstract available
    
    
    
95. CACACE R, Van Broeckhoven C
    Reply: Lack of evidence supporting a role for DPP6 sequence variants in Alzheimer's disease in the European American population.
    Acta Neuropathol. 2021 Feb 16. pii: 10.1007/s00401-021-02277.
    PubMed    
    
    
    
96. KIROLA L, Budde JP, Wang F, Norton J, et al
    Lack of evidence supporting a role for DPP6 sequence variants in Alzheimer's disease in the European American population.
    Acta Neuropathol. 2021 Feb 16. pii: 10.1007/s00401-021-02271.
    PubMed    
    
    
    
97. ASHTON NJ, Pascoal TA, Karikari TK, Benedet AL, et al
    Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
    Acta Neuropathol. 2021 Feb 14. pii: 10.1007/s00401-021-02275.
    PubMed     Abstract available
    
    
    
98. ARAGAO GOMES L, Uytterhoeven V, Lopez-Sanmartin D, Tome SO, et al
    Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation.
    Acta Neuropathol. 2021;141:173-192.
    PubMed     Abstract available
    
    
    
99. XU H, O'Reilly M, Gibbons GS, Changolkar L, et al
    In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics.
    Acta Neuropathol. 2021;141:193-215.
    PubMed     Abstract available
    
    
    January 2021
100. HONDIUS DC, Koopmans F, Leistner C, Pita-Illobre D, et al
     The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer's disease.
     Acta Neuropathol. 2021 Jan 25. pii: 10.1007/s00401-020-02261.
     PubMed     Abstract available
     
     
     
101. MATCHETT BJ, Grinberg LT, Theofilas P, Murray ME, et al
     The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease.
     Acta Neuropathol. 2021 Jan 11. pii: 10.1007/s00401-020-02248.
     PubMed     Abstract available
     
     
     December 2020
102. SEPULVEDA-FALLA D, Chavez-Gutierrez L, Portelius E, Velez JI, et al
     A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease.
     Acta Neuropathol. 2020 Dec 14. pii: 10.1007/s00401-020-02249.
     PubMed     Abstract available
     
     
     October 2020
103. VAILLANT-BEUCHOT L, Mary A, Pardossi-Piquard R, Bourgeois A, et al
     Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains.
     Acta Neuropathol. 2020 Oct 20. pii: 10.1007/s00401-020-02234.
     PubMed     Abstract available
     
     
     September 2020
104. EVANS CE, Miners JS, Piva G, Willis CL, et al
     Correction to: ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
     Acta Neuropathol. 2020 Sep 27. pii: 10.1007/s00401-020-02229.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.